Search

everythinglearnresearchcommunity

for

Search:↓

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

Polycystic ovary syndrome (PCOS) significantly impacts women's emotional well-being and social lives, requiring treatments that include psychological support.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Only 22% of teenage girls in the study knew about PCOS, despite many having symptoms.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Irisin and GIP levels are not linked to BMI in women, regardless of PCOS status.